Beam Therapeutics Inc.

BEAM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$25.91+1.53%

2026-08-03

Financials

Valuation Metrics

Beam Therapeutics Inc.'s Market Cap is $2.67B. At end of 2025 it was $2.85B. Ranked #1863 of 3,112 in US market (top 60%), #684 of 1,445 on NASDAQ (top 47%), #109 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 41%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$2.67B	US#1,863/3,112 Sec#109/269
Revenue	$164M	US#2,716/3,112 Sec#116/269
Net Income	$-65M	US—/3,112 Sec—/269
Total Assets	$1.48B	US#2,238/3,112 Sec#66/269
Net Assets	$1.16B	US#1,678/3,112 Sec#58/269
Value
P/B	2.29x	US#1,357/3,112 Sec#63/269
P/S	16.25x	US#2,777/3,112 Sec#141/269
FCF Yield	-14.40%	US—/3,112 Sec—/269
Profitability
ROE	-5.59%	US#2,326/3,112 Sec#85/269
ROA	-4.39%	US#2,500/3,112 Sec#92/269
Op. Margin	-226.58%	US#2,868/3,112 Sec#145/269
Revenue Growth	324.87%	US#46/3,112 Sec#16/269
Financial Health
Debt Ratio	27.17%	US#294/3,112 Sec#96/269
Total Debt	$251M	US#2,107/3,112 Sec#84/269
FCF	$-384M	US#2,808/3,112 Sec#249/269
Cash	$288M	US#1,462/3,112 Sec#84/269
Current Ratio	16.99x	US#148/3,112 Sec#45/269
Performance
1Y Return	37.60%	US#1,038/3,112 Sec#136/269
1M Return	-25.52%	US#3,027/3,112 Sec#247/269
From 52W High	-32.28%	US#2,263/3,112 Sec#171/269
1Y MDD	-38.15%	US#1,861/3,112 Sec#135/269
Trading
Volume	1,260,285 shares	US#1,282/3,112 Sec#125/269
Trading Value	$32M	US#1,673/3,112 Sec#113/269
Per Share
EPS	$-0.78	US—/3,112 Sec—/269
BPS	$12.04	US#1,659/3,112 Sec#54/269